Western Galilee Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Nahariya Israel (1956)

Organization Overview

First Clinical Trial
2006
NCT00496184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Director of Ophthalmology Department, Western Galilee Medical Center, Nahariya, Israel | Western Galilee Hospital-Nahariya | Western Galilee Hospital, Nahariya, Israel

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Fetal Membranes, Premature Rupture (Phase 4)

Kidney Failure, Chronic (Phase 3)

Premature Birth (Phase 4)

Presbyopia (Phase 2)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Rupture (Phase 4)

Vulvar Diseases (Phase 3)

Vulvar Vestibulitis (Phase 3)

Vulvodynia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial APIs: 33